192 related articles for article (PubMed ID: 33792841)
1. SEOM clinical guideline for management of adult medulloblastoma (2020).
Luque R; Benavides M; Del Barco S; Egaña L; García-Gómez J; Martínez-García M; Pérez-Segura P; Pineda E; Sepúlveda JM; Vieito M
Clin Transl Oncol; 2021 May; 23(5):940-947. PubMed ID: 33792841
[TBL] [Abstract][Full Text] [Related]
2. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
4. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
6. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
7. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
[TBL] [Abstract][Full Text] [Related]
8. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
von Bueren AO; von Hoff K; Pietsch T; Gerber NU; Warmuth-Metz M; Deinlein F; Zwiener I; Faldum A; Fleischhack G; Benesch M; Krauss J; Kuehl J; Kortmann RD; Rutkowski S
Neuro Oncol; 2011 Jun; 13(6):669-79. PubMed ID: 21636711
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma: presentation, diagnosis and management.
Packer RJ; Finlay JL
Oncology (Williston Park); 1988 Sep; 2(9):35-45, 48-9. PubMed ID: 3275066
[TBL] [Abstract][Full Text] [Related]
11. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
12. Childhood medulloblastoma: progress and future challenges.
Packer RJ
Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma in Older Adults: A Case Report and Literature Review.
Murase M; Saito K; Abiko T; Yoshida K; Tomita H
World Neurosurg; 2018 Sep; 117():25-31. PubMed ID: 29883827
[TBL] [Abstract][Full Text] [Related]
14. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
15. Management of pediatric and adult patients with medulloblastoma.
Martin AM; Raabe E; Eberhart C; Cohen KJ
Curr Treat Options Oncol; 2014 Dec; 15(4):581-94. PubMed ID: 25194927
[TBL] [Abstract][Full Text] [Related]
16. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
[TBL] [Abstract][Full Text] [Related]
17. Metachronous Medulloblastoma in a Child With Successfully Treated Neuroblastoma: Case Report and Novel Findings of DNA Sequencing.
Eterovic AK; Maher OM; Chandra J; Chen K; Huse J; Zaky W
J Natl Compr Canc Netw; 2018 Jun; 16(6):683-691. PubMed ID: 29891519
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma: an Old Diagnosis with New Promises.
Szalontay L; Khakoo Y
Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
[TBL] [Abstract][Full Text] [Related]
19. Current multimodality management of medulloblastoma.
Paulino AC
Curr Probl Cancer; 2002; 26(6):317-56. PubMed ID: 12447347
[No Abstract] [Full Text] [Related]
20. Cerebellar medulloblastomas in adults.
Tekkök IH; Süzer T; Ozgen T; Erbengi A
Neurosurg Rev; 1991; 14(2):135-40. PubMed ID: 1870719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]